SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-067320
Filing Date
2021-12-01
Accepted
2021-12-01 17:56:05
Documents
2
Period of Report
2021-11-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2208
2 POA DOCUMENT poa.txt EX-24 3762
  Complete submission text file 0001209191-21-067320.txt   7422
Mailing Address C/O AXCELLA HEALTH INC. 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Chardonnet Laurent (Reporting) CIK: 0001329010 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39527 | Film No.: 211464152

Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Issuer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations